Tosteson AN - Search Results

1

Quality-of-life assessment in osteoporosis: health-status and preference-based measures.

Tosteson AN, Hammond CS. Tosteson AN, et al. Pharmacoeconomics. 2002;20(5):289-303. doi: 10.2165/00019053-200220050-00001. Pharmacoeconomics. 2002. PMID: 11994039

2

Quality of life in the economic evaluation of osteoporosis prevention and treatment.

Tosteson AN. Tosteson AN. Spine (Phila Pa 1976). 1997 Dec 15;22(24 Suppl):58S-62S. doi: 10.1097/00007632-199712151-00010. Spine (Phila Pa 1976). 1997. PMID: 9431646 Review.

3

Has the impact of hormone replacement therapy on health-related quality of life been undervalued?

Tosteson AN, Gabriel SE, Kneeland TS, Moncur MM, Manganiello PD, Schiff I, Ettinger B, Melton LJ 3rd. Tosteson AN, et al. J Womens Health Gend Based Med. 2000 Mar;9(2):119-30. doi: 10.1089/152460900318614. J Womens Health Gend Based Med. 2000. PMID: 10746515

4

Measuring health state preferences in women with breast hypertrophy.

Kerrigan CL, Collins ED, Kneeland TS, Voigtlaender D, Moncur MM, Matheney TH, Grove MR, Tosteson AN. Kerrigan CL, et al. Among authors: tosteson an. Plast Reconstr Surg. 2000 Aug;106(2):280-8. doi: 10.1097/00006534-200008000-00005. Plast Reconstr Surg. 2000. PMID: 10946925

5

Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions.

Tosteson AN, Jönsson B, Grima DT, O'Brien BJ, Black DM, Adachi JD. Tosteson AN, et al. Osteoporos Int. 2001;12(10):849-57. doi: 10.1007/s001980170036. Osteoporos Int. 2001. PMID: 11716188

6

Impact of hip and vertebral fractures on quality-adjusted life years.

Tosteson AN, Gabriel SE, Grove MR, Moncur MM, Kneeland TS, Melton LJ 3rd. Tosteson AN, et al. Osteoporos Int. 2001 Dec;12(12):1042-9. doi: 10.1007/s001980170015. Osteoporos Int. 2001. PMID: 11846331

7

Automated current health time-trade-off assessments in women's health.

Tosteson AN, Kneeland TS, Nease RF, Sumner W. Tosteson AN, et al. Value Health. 2002 Mar-Apr;5(2):98-105. doi: 10.1046/j.1524-4733.2002.52102.x. Value Health. 2002. PMID: 11918825 Free article.

8

Direct medical costs attributable to osteoporotic fractures.

Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ 3rd. Gabriel SE, et al. Among authors: tosteson an. Osteoporos Int. 2002;13(4):323-30. doi: 10.1007/s001980200033. Osteoporos Int. 2002. PMID: 12035765

9

Early discontinuation of treatment for osteoporosis.

Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B. Tosteson AN, et al. Am J Med. 2003 Aug 15;115(3):209-16. doi: 10.1016/s0002-9343(03)00362-0. Am J Med. 2003. PMID: 12947959

10

Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

McDonough CM, Tosteson AN. McDonough CM, et al. Among authors: tosteson an. Pharmacoeconomics. 2007;25(2):93-106. doi: 10.2165/00019053-200725020-00003. Pharmacoeconomics. 2007. PMID: 17249853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters